{"disease":{"id":"scarring-alopecia","name":"scarring alopecia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06512766","title":"a Retrospective Study on the Systemic Treatment of LPP and FFA","phase":"","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT03078686","title":"Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Regeneris Medical","has_results":false},{"nct_id":"NCT00691769","title":"Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia","phase":"","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Wake Forest University","has_results":false},{"nct_id":"NCT03346668","title":"Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University of Minnesota","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}